ollielooya
True Blue
Here is the following chart note that accompanies an E/M visit: BILATERAL OCCIPITAL NERVE BLOCK/TRIGGER POINT INJECTIONS
Patient was consented for bilateral occipital nerve blocks and trigger point injections. A solution containing 4.5-cc of 2% Lidocaine, 4.5-cc of 0.5% Sensorcaine, and 1.0 cc of Kenalog (40 mg) for a total of 10-cc was prepared in a 10 CC syringe. Two syringes containing the same solution were prepared.
Target areas in the suboccipital region were identified via palpation and pain response. The trigger sites were marked. The occipitocervical junctions were sterilized with alcohol wipes. The contents of each syringe was injected in a fanlike fashion on each side.
The headaches essentially resolved and she still had pain on the left occipitocervical junction. The trigger site was identified and marked. A solution containing 2.5 mL of 0.5% Marcaine and 2.5 mL of 2% Lidocaine was prepared. The trigger site was injected. The occipital headaches resolved.
Patient tolerated the procedure well and no complications were noted.
Patient was monitored and discharged in stable condition. Patient had a driver.
At a time of discharge, the vitals were xxx/xx, xx
------------------------------------------------
code choices: 99214, 64400-50, 64405-50, 51, 64400-50,51, 96372, and accompanying J codes. My question concerns the 96372 in this particular case. Because the nerve blocks were bilateral, the TWO injections are considered bundled into the procedures, correct? I could still bill for the 3rd injection with a 59? How shall the 96372's be notated? Therefore, do I just include ONE unit of 96372 with modifer 59? Or do I bill for the 2 units of 96372 (knowing it will be bundled), and 1 unit on a separate line with 59? Thanks for helping me before. About the time I think I'm getting the idea, hesitation settles in.
Suzanne, CPC-A
Patient was consented for bilateral occipital nerve blocks and trigger point injections. A solution containing 4.5-cc of 2% Lidocaine, 4.5-cc of 0.5% Sensorcaine, and 1.0 cc of Kenalog (40 mg) for a total of 10-cc was prepared in a 10 CC syringe. Two syringes containing the same solution were prepared.
Target areas in the suboccipital region were identified via palpation and pain response. The trigger sites were marked. The occipitocervical junctions were sterilized with alcohol wipes. The contents of each syringe was injected in a fanlike fashion on each side.
The headaches essentially resolved and she still had pain on the left occipitocervical junction. The trigger site was identified and marked. A solution containing 2.5 mL of 0.5% Marcaine and 2.5 mL of 2% Lidocaine was prepared. The trigger site was injected. The occipital headaches resolved.
Patient tolerated the procedure well and no complications were noted.
Patient was monitored and discharged in stable condition. Patient had a driver.
At a time of discharge, the vitals were xxx/xx, xx
------------------------------------------------
code choices: 99214, 64400-50, 64405-50, 51, 64400-50,51, 96372, and accompanying J codes. My question concerns the 96372 in this particular case. Because the nerve blocks were bilateral, the TWO injections are considered bundled into the procedures, correct? I could still bill for the 3rd injection with a 59? How shall the 96372's be notated? Therefore, do I just include ONE unit of 96372 with modifer 59? Or do I bill for the 2 units of 96372 (knowing it will be bundled), and 1 unit on a separate line with 59? Thanks for helping me before. About the time I think I'm getting the idea, hesitation settles in.
Suzanne, CPC-A